BioSpace News Archive

Advantech, a leading provider of medically certified computing products and advanced IoT intelligence systems, will return to the 2020 HIMSS Conference, March 9-13 at the Orange County Convention Center in Orlando, Fla.

A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a new treatment for cancer, in which blood vessels within malignant tumors are normalized by injecting a specially developed nanodelivery system for nitric oxide, which also facilitates the delivery of cancer drugs and immunocytes into the tumor.

Oerth Bio (pronounced “Earth”), an agricultural biotech company, today announced several key leadership hires.

The 2020 Status of Health Equity Report released by The Root Cause Coalition, of which National Health Foundation is a member, captures some of the progress -as well as gaps- in addressing health disparities, and socioeconomic factors influencing individual and community health.

Breezie, a multitiered tablet-based platform that drives senior engagement and compliance, announced this week that it has been acquired by VitalTech, a rapidly growing market leader in connected care, digital health and remote patient monitoring.

Outlook Therapeutics, Inc. announced that it has closed its previously-announced registered direct offering priced at-the-market under Nasdaq rules of 7,598,426 shares of its common stock, at a combined purchase price of $1.016 per share and associated unregistered warrant, for aggregate gross proceeds of approximately $7.72 million.

Johnson & Johnson will participate in the Barclays Global Healthcare Conference on Wednesday, March 11th, at the Loews Miami Beach Hotel, Miami Beach, FL. Ciro Romer, Company Group Chairman, Medical Devices North America will represent the Company in a session scheduled at 10:15 a.m.

CEL-SCI Corporation issued a letter to its shareholders. This letter will be sent to the Company’s shareholders along with the proxy to the upcoming annual meeting.

Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the Cowen and Company 40 th Annual Health Care Conference on Tuesday, March 3, 2020 at 11:20 a.m. ET in Boston.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced it proposes to elect Doug Treco, Ph.D. to its Board of Directors at the Company’s upcoming annual general meeting to be held later this year.